Published in J Neurosurg on October 01, 1998
Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas. J Neurosurg Pediatr (2014) 2.07
Effect of concentration on the accuracy of convective imaging distribution of a gadolinium-based surrogate tracer. J Neurosurg (2011) 1.87
Image-guided convection-enhanced delivery of muscimol to the primate brain. J Neurosurg (2010) 1.29
Convection-enhanced delivery for the treatment of pediatric neurologic disorders. J Child Neurol (2008) 0.98
Convection-enhanced delivery for the treatment of glioblastoma. Neuro Oncol (2015) 0.85
A voxelized model of direct infusion into the corpus callosum and hippocampus of the rat brain: model development and parameter analysis. Med Biol Eng Comput (2009) 0.85
Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease. Mol Med (1999) 0.85
Voxelized model of interstitial transport in the rat spinal cord following direct infusion into white matter. J Biomech Eng (2009) 0.83
Predictive models for pressure-driven fluid infusions into brain parenchyma. Phys Med Biol (2011) 0.83
Progressive peritumoral edema defining the optic fibers and resulting in reversible visual loss. J Neurosurg (2008) 0.82
Tracking accuracy of T2- and diffusion-weighted magnetic resonance imaging for infusate distribution by convection-enhanced delivery. J Neurosurg (2011) 0.82
Anatomical differences determine distribution of adenovirus after convection-enhanced delivery to the rat brain. PLoS One (2011) 0.79
Convection-enhanced drug delivery for gliomas. Surg Neurol Int (2015) 0.78
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications. Pharmaceuticals (Basel) (2012) 0.77
In vivo contrast-enhanced MR imaging of direct infusion into rat peripheral nerves. Ann Biomed Eng (2011) 0.76
Neurological surgery at the National Institutes of Health. World Neurosurg (2010) 0.75
Time-reversal Techniques in Ultrasound-assisted Convection-enhanced Drug Delivery to the Brain: Technology Development and In Vivo Evaluation. Proc Meet Acoust (2011) 0.75
Direct convective macromolecule delivery. J Neurosurg (1999) 0.75
Convection-Enhanced Delivery. Neurotherapeutics (2017) 0.75
Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A (1994) 6.61
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (1992) 5.47
Elucidating the pathophysiology of syringomyelia. J Neurosurg (1999) 4.43
Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci U S A (1996) 3.88
The cocaine 'body packer' syndrome. Diagnosis and treatment. JAMA (1983) 2.97
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol (2001) 2.86
Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med (1997) 2.76
In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res (1993) 2.74
Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest (1993) 2.42
Synaptic modulation of calcium-dependent potassium conductance in myenteric neurones in the guinea-pig. J Physiol (1980) 2.41
Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med (1997) 2.39
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res (1992) 2.17
Imaging normal and abnormal brain development: new perspectives for child psychiatry. Aust N Z J Psychiatry (2001) 2.09
Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci (1990) 2.04
High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol (1994) 2.01
The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison. Ann Intern Med (1994) 2.00
Serotonergic activation of tonic-type enteric neurons in guinea pig small bowel. J Neurophysiol (1979) 1.97
Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg (1999) 1.97
Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg (1995) 1.94
Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol (1993) 1.93
Spinal arteriovenous malformations: a comparison of dural arteriovenous fistulas and intradural AVM's in 81 patients. J Neurosurg (1987) 1.92
A correlation between changes in GABA metabolism and isonicotinic acid hydrazide-induced seizures. Brain Res (1972) 1.79
Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med (1994) 1.78
Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. Am J Physiol (1999) 1.77
Reversible acute and subacute myelopathy in patients with dural arteriovenous fistulas. Foix-Alajouanine syndrome reconsidered. J Neurosurg (1989) 1.75
Brief report: relief of spinal cord compression from vertebral hemangioma by intralesional injection of absolute ethanol. N Engl J Med (1994) 1.75
Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol (1996) 1.75
von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol (1997) 1.74
Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med (1994) 1.70
Multiple pituitary adenomas in Cushing's disease. J Neurosurg (2000) 1.63
Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J Clin Invest (1996) 1.63
Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA (1997) 1.63
Electrical activity from single neurons in Auerbach's plexus. Am J Physiol (1970) 1.60
Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates. J Neurosurg (1999) 1.59
Symptomatic vertebral hemangiomas: treatment by means of direct intralesional injection of ethanol. Radiology (2000) 1.58
Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology (2006) 1.57
Surgical interruption of intradural draining vein as curative treatment of spinal dural arteriovenous fistulas. J Neurosurg (1995) 1.56
Tumor devascularization by intratumoral ethanol injection during surgery. Technical note. J Neurosurg (1998) 1.55
Bilateral sampling of the internal jugular vein to distinguish between mechanisms of adrenocorticotropic hormone-dependent Cushing syndrome. Ann Intern Med (1998) 1.54
Selective excision of adenomas originating in or extending into the pituitary stalk with preservation of pituitary function. J Neurosurg (1997) 1.49
Extrapituitary parasellar microadenoma in Cushing's disease. J Clin Endocrinol Metab (1999) 1.49
The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J Neurosurg (1990) 1.48
Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro. J Neurosurg (1991) 1.46
Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med (1989) 1.46
Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther (1993) 1.44
Intracellular study of electrical activity of Auerbach's plexus in guinea-pig small intestine. Pflugers Arch (1978) 1.39
Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci (1986) 1.39
The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med (1984) 1.36
Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol (1999) 1.35
Direct convective delivery of macromolecules to peripheral nerves. J Neurosurg (1998) 1.35
Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Ther (1997) 1.33
Excitation of intestinal muscle by atropine, tetrodotoxin, and xylocaine. Am J Physiol (1972) 1.33
Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg (1997) 1.32
Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res (1997) 1.31
Neurosurgical implications of Carney complex. J Neurosurg (2000) 1.30
Electrical activity of the intestine of mice with hereditary megacolon and absence of enteric ganglion cells. Am J Dig Dis (1973) 1.28
Intratumoral LAK cell and interleukin-2 therapy of human gliomas. J Neurosurg (1989) 1.27
Effects of forskolin on electrical behaviour of myenteric neurones in guinea-pig small intestine. J Physiol (1986) 1.26
Cortical electrical stimulation alters erythrocyte perfusion pattern in the cerebral capillary network of the rat. Brain Res (2003) 1.25
Intracellular study of tonic-type enteric neurons in guinea pig small intestine. J Neurophysiol (1979) 1.25
Slow excitatory synaptic transmission mediated by P2Y1 receptors in the guinea-pig enteric nervous system. J Physiol (2003) 1.24
Elevation of adenosine 3',5'-phosphate mimics slow synaptic excitation in myenteric neurones of the guinea-pig. J Physiol (1986) 1.23
Slow synaptic excitation mediated by serotonin in Auerbach's plexus. Nature (1979) 1.22
Enteric neurophysiology. Am J Physiol (1984) 1.21
Management of the ectopic ACTH syndrome due to thoracic carcinoids. Ann Thorac Surg (1990) 1.20
Synaptic behavior of myenteric neurons in guinea pig distal colon. Am J Physiol (1988) 1.19
Electrical behaviour of myenteric neurones in the gastric corpus of the guinea-pig. J Physiol (1989) 1.16
Transduction of aminergic and peptidergic signals in enteric neurones of the guinea-pig. J Physiol (1987) 1.15
Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab (2001) 1.14
Immunoreactivity of Hu proteins facilitates identification of myenteric neurones in guinea-pig small intestine. Neurogastroenterol Motil (2002) 1.14
Motility of the large intestine of piebald-lethal mice. Am J Dig Dis (1976) 1.14
Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab (1999) 1.14
Intracellular study of effects of histamine on electrical behaviour of myenteric neurones in guinea-pig small intestine. J Physiol (1984) 1.13
Effects of neuronal stimulation on mucosal transport in guinea pig ileum. Am J Physiol (1983) 1.13
Flavour perception of oxidation in beef. Meat Sci (2005) 1.13
Successful treatment of a group of spinal cord arteriovenous malformations by interruption of dural fistula. J Neurosurg (1983) 1.13
Resection of suprasellar tumors by using a modified transsphenoidal approach. Report of four cases. J Neurosurg (2000) 1.13
Treatment of cranial dural arteriovenous fistulae by interruption of leptomeningeal venous drainage. J Neurosurg (1994) 1.12
Neuroimmune communication in the submucous plexus of guinea pig colon after sensitization to milk antigen. Am J Physiol (1994) 1.12
Neuroimmune communication in the submucous plexus of guinea pig colon after infection with Trichinella spiralis. Gastroenterology (1994) 1.12
Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. J Neurosurg (1987) 1.12
A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab (1994) 1.12
Evolution of VHL tumourigenesis in nerve root tissue. J Pathol (2006) 1.11
Esophageal contractions induced by vagal stimulation in the opossum. Am J Physiol (1978) 1.10
Mechanical interaction between longitudinal and circular axes of the small intestine. Am J Physiol (1970) 1.09
Early repeat surgery for persistent Cushing's disease. J Neurosurg (1994) 1.09
Polyglutamine pathogenesis. Philos Trans R Soc Lond B Biol Sci (1999) 1.08
beta 1-adrenergic receptor association with the synaptic scaffolding protein membrane-associated guanylate kinase inverted-2 (MAGI-2). Differential regulation of receptor internalization by MAGI-2 and PSD-95. J Biol Chem (2001) 1.08